CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300409740
- Phone
- (415) 651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-30 | BVF PARTNERS L P/IL Director | Purchase | +341,977 | $9.39 | $3.2M | 2,865,242 |
| 2021-11-30 | BVF PARTNERS L P/IL Director | Purchase | +35,268 | $9.39 | $331K | 471,350 |
| 2021-11-29 | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | Sale | −400 | $24.76 | $10K | 1,051,146 |
| 2021-11-10 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise | +5,251 | $2.06 | $11K | 7,041 |
| 2021-11-10 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise | +22,417 | $19.00 | $426K | 29,458 |
| 2021-11-10 | Horn Kinney CHIEF BUSINESS OFFICER | Sale | −27,668 | $26.88 | $744K | 1,790 |
| 2021-11-10 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) | −5,251 | 162,791 | ||
| 2021-11-10 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) | −22,417 | 67,253 | ||
| 2021-10-19 | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | Sale | −7,445 | $27.85 | $207K | 1,056,101 |
| 2021-10-19 | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | Sale | −4,555 | $28.20 | $128K | 1,051,546 |
| 2021-10-14 | Bohen Sean PRESIDENT AND CEO | Option exercise | +5,000 | $4.82 | $24K | 57,514 |
| 2021-10-14 | Bohen Sean PRESIDENT AND CEO | Sale | −4,649 | $30.42 | $141K | 52,865 |
| 2021-10-14 | Bohen Sean PRESIDENT AND CEO | Sale | −351 | $31.17 | $11K | 52,514 |
| 2021-10-14 | Bohen Sean PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) | −5,000 | 966,316 | ||
| 2021-10-11 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise | +5,251 | $2.06 | $11K | 7,041 |
| 2021-10-11 | Horn Kinney CHIEF BUSINESS OFFICER | Sale | −2,105 | $27.47 | $58K | 4,936 |
| 2021-10-11 | Horn Kinney CHIEF BUSINESS OFFICER | Sale | −3,146 | $28.19 | $89K | 1,790 |
| 2021-10-11 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) | −5,251 | 168,042 | ||
| 2021-09-27 | Bohen Sean PRESIDENT AND CEO | Option exercise | +1,085 | $4.82 | $5K | 53,599 |
| 2021-09-27 | Bohen Sean PRESIDENT AND CEO | Sale | −1,085 | $30.07 | $33K | 52,514 |
Page 16 of 21 · 402 trades